In the wake of mounting evidence for the efficacy of psychedelic-assisted therapies, the U.S. Food and Drug Administration (FDA) is considering approving psilocybin, the active ingredient in 'magic mushrooms,' for treating depression in the near future.
Millions of depressed Americans could benefit from psychedelic therapy, study finds retrieved 13 September 2024 from https://medicalxpress.com/news/2024-09-millions-depressed-americans-benefit-psychedelic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Manx food truck launches insurance against food theft by gullsManx customers are offered 'seagull insurance' in case their snacks are 'snatched' by the birds.
Read more »
How the Parkinson's drug Levodopa causes psychiatric complications similar to drug abuseResearchers at Karolinska Institutet have identified a mechanism responsible for a serious psychiatric complication caused by dopamine replacement therapy in Parkinson's disease. The results of these findings were recently published in Molecular Psychiatry.
Read more »
Japan is recycling food waste back into food with fermentationA unique fermentation method being piloted in Japan transforms edible leftovers and scraps into sustainable feed for pigs.
Read more »
Fentanyl still deadliest drug in Florida as overall deaths decline and another synthetic drug risesThe number of Floridians who died from drugs last year decreased across the state, but one synthetic drug was noticeably on the rise and fentanyl is still the deadliest drug of all, according to a statewide report released this summer.
Read more »
UK drug regulator approves Alzheimer's drug but government likely won't pay for itBritain's drug regulator authorized the Alzheimer's drug Leqembi on Thursday, saying it's the first medicine to show some impact in slowing the progression of the neurodegenerative disease.
Read more »
Trial finds drug-coated balloon angioplasty less effective than second generation drug-eluting stentsNovel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).
Read more »